BioNJ’s Manufacturing Brief returned to an in-person format Friday at the New Jersey Institute of Technology’s Newark campus.
“This is our first in-person biomanufacturing conference in two years,” said Debbie Hart, president and CEO, BioNJ. “At BioNJ, we want to make sure that we’re supporting New Jersey’s life sciences ecosystem and make sure that it is a place where innovation is happening unencumbered and then patients can access that innovation.”
The pandemic played a central role in the topics and issues covered during the event, with many panels focused on navigating the new normal that COVID-19 has created in the world and within the biomanufacturing industry.
“Biomanufacturing has been evolving over many years recently, and not ever more so than during COVID-19,” said Hart. “And this discussion today, I think it’s really timely and important. We have an impressive roster of thought leaders with us.”
And the briefing certainly featured an impressive group of speakers and panelists discussing topics including industry trends shaping the manufacturing strategy of the future, lessons learned from the pandemic, incorporating innovation into future manufacturing strategy, methods to accelerate manufacturing performance and productivity of tomorrow, and more.
“It’s so good to be back in this environment here at the beautiful NJIT in this beautiful building,” said Hart. “And just to be back together is really wonderful. We have been here before and this will be our largest turnout ever.”
NJBIZ’s upcoming Sept. 19 issue will feature a closer look at some of those issues, challenges and solutions tackled during the briefing.